American Journal of Nephrology

Papers
(The H4-Index of American Journal of Nephrology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy366
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage86
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review61
Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the Present47
Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents46
Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial46
Starvation Ketosis and the Kidney41
New Onset Biopsy-Proven Nephropathies after COVID Vaccination35
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome35
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis33
Efficacy and Safety of Molidustat for Anemia in ESA-Naive Nondialysis Patients: A Randomized, Phase 3 Trial32
Machine Learning for Prediction and Risk Stratification of Lupus Nephritis Renal Flare31
The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease30
Molidustat for Renal Anemia in Nondialysis Patients Previously Treated with Erythropoiesis-Stimulating Agents: A Randomized, Open-Label, Phase 3 Study28
Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel26
The Forgotten Antiproteinuric Properties of Diuretics25
Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives22
Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)22
Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes22
Epidemiology and Outcomes of Acute Kidney Diseases: A Comparative Analysis21
High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study20
LRG1 Mitigates Renal Interstitial Fibrosis through Alleviating Capillary Rarefaction and Inhibiting Inflammatory and Pro-Fibrotic Cytokines20
Dietary Factors and Prevention: Risk of End-Stage Kidney Disease by Fruit and Vegetable Consumption20
0.054058074951172